Macquarie Group LTD Heron Therapeutics, Inc. Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $1,135 - $2,292	-427 Reduced 5.75%	6,996 $31,000
Q4 2021 Feb 11, 2022	SELL	$8.35 - $12.6 $15,848 - $23,914	-1,898 Reduced 20.36%	7,423 $68,000
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $53,648 - $79,440	5,296 Added 131.58%	9,321 $100,000
Q1 2021 May 14, 2021	SELL	$14.49 - $20.72 $15,967 - $22,833	-1,102 Reduced 21.49%	4,025 $65,000
Q3 2020 Nov 13, 2020	BUY	$13.67 - $17.77 $10,936 - $14,216	800 Added 18.49%	5,127 $76,000
Q2 2020 Aug 11, 2020	BUY	$10.89 - $21.47 $47,121 - $92,900	4,327 New	4,327 $64,000

174

114M

1.99M

65.8K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $211M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.